ArticlemSphere2018
Open access · goldAbstract read
In one paragraph
Article in mSphere, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
153 citing papers in PubMed, 1 synthesis or guideline pooled it, 230 citations in OpenAlex.
- Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.Clinical microbiology reviews · 2019Pooled it
- Intestinal colonization of weaner pigs by extended-spectrum-β-lactamase-encoding Escherichia coli classified for differential host-association using a phylogenetics-based approach.Scientific reports · 2026Article
- Carbapenem resistance in community-acquired urinary tract infections caused byJAC-antimicrobial resistance · 2026Article
- Carbapenemases: epidemiology, detection and management in a changing global landscape.JAC-antimicrobial resistance · 2026Review
- Role of Mobilome in Carbapenem Resistance.Antibiotics (Basel, Switzerland) · 2026Review
- Outbreak and dissemination of the international high-risk NDM-5-producingZoological research · 2026Article
- Expanding Threat of Carbapenemase-ProducingbioRxiv : the preprint server for biology · 2026Article
- TheMicrobial genomics · 2026Article
- Genomic characterization of multidrug-resistant Escherichia coli strains identified from patients with urinary tract infection in Egypt.Scientific reports · 2026Article
- Multidrug-Resistant Pathogen Clonal Spread in Nigeria: A Systematic Review and Meta-Analysis.Health science reports · 2026Review
- Genomic analysis of the virulome and resistome of high-riskJAC-antimicrobial resistance · 2026Article
- Genomic characterization and sub-clustering of Escherichia coli clonal complex 38 reveal host associated genetic markers.Communications medicine · 2026Article
- Antimicrobial Resistance and Comparative Genome Analysis of High-RiskMicroorganisms · 2026Article
- High-pathogenicity island enhances NDM-5 activity and drives global spread of Escherichia coli ST410.The ISME journal · 2026Article
- The Caribbean under the radar? A scoping review of carbapenemase-producing Enterobacterales across the region.PLOS global public health · 2026Article
- Comparative Genomics of Human- and Wastewater-Derived CPE Isolates in The Netherlands Reveals Shared and Complementary Characteristics.Microorganisms · 2025Article
- ESBL-producingOne health (Amsterdam, Netherlands) · 2025Article
- The emergence of highly resistant and hypervirulentEmerging microbes & infections · 2025Article
- Molecular characterization of ESBL- and carbapenemase-producing Enterobacteriaceae isolated from cats in Lebanon.BMC microbiology · 2025Article
- Identification of plasmid-mediated tigecycline resistanceMicrobiology spectrum · 2025Article
93 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 12 institutions in 5 countries.
Louise RoerDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Søren Overballe-PetersenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Frank HansenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Kristian SchønningDepartment of Clinical Microbiology, Hvidovre University Hospital, Hvidovre, Denmark.ORCID 0000-0001-7767-305X
Mikala WangDepartment of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
Bent L RøderDepartment of Clinical Microbiology, Slagelse Hospital, Slagelse, Denmark.
Dennis S HansenDepartment of Clinical Microbiology, Herlev and Gentofte Hospital, Herlev, Denmark.
Ulrik S JustesenDepartment of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Leif P AndersenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
David Fulgsang-DamgaardDepartment of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
Katie L HopkinsAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
Neil WoodfordAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
Linda FalgenhauerInstitute of Medical Microbiology, Justus Liebig University Giessen and German Centre for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Giessen, Germany.
Trinad ChakrabortyInstitute of Medical Microbiology, Justus Liebig University Giessen and German Centre for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Giessen, Germany.
Ørjan SamuelsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Karin SjöströmPublic Health Agency of Sweden, Stockholm, Sweden.
Thor B JohannesenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Kim NgDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Jens NielsenDepartment of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Steen EthelbergDepartment of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Marc SteggerDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0003-0321-1180
Anette M HammerumDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark ama@ssi.dk.
Henrik HasmanDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Statens Serum Institut · DKJustus-Liebig-Universität Gießen · DEPublic Health England · GBAalborg University Hospital · DKAarhus University Hospital · DKGentofte Hospital · DKOdense University Hospital · DKPublic Health Agency of Sweden · SERigshospitalet · DKSlagelse Hospital · DKUniversity Hospital of North Norway · NOUniversity of Copenhagen · DK
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Evolution, MolecularGenotypeBacterial Proteinsbeta-LactamasesDenmarkDisease OutbreaksEscherichia coli InfectionsExtraintestinal Pathogenic Escherichia coliHumansMultilocus Sequence TypingPrevalenceProspective StudiesWhole Genome SequencingBacterial Proteinsbeta-LactamasescarbapenemaseBEASTepidemiologyEscherichia colievolutionhigh-risk cloneoutbreak
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.